a laser afternoon: introduction
DESCRIPTION
A Laser Afternoon: Introduction. Ken Peach Particle Therapy Cancer Research Institute (Oxford Martin School) & John Adams Institute for Accelerator Science, University of Oxford Imperial College December 13 th 2012. - PowerPoint PPT PresentationTRANSCRIPT
http://www.ptcri.ox.ac.uk [email protected]
A Laser Afternoon:Introduction
Ken PeachParticle Therapy Cancer Research Institute (Oxford Martin School)
&John Adams Institute for Accelerator Science, University of Oxford
Imperial CollegeDecember 13th 2012
The tax mans taken all my dough,And left me in my stately home,Lazing on a sunny afternoon.
Ray Davis (The Kinks) “Sunny Afternoon”
Ken Peach A Laser Afternoon: Introduction Imperial College, December 13th 2012 2
Outline
• What is needed?• Where could we help?• What should we do?
Ken Peach A Laser Afternoon: Introduction Imperial College, December 13th 2012 3
WHAT IS NEEDED?
TherapyRadiobiology
Ken Peach A Laser Afternoon: Introduction Imperial College, December 13th 2012 4
100
80
60
40
20
50 100 150
SOBP
Pristine peak
Depth (mm)
Dos
e (%
)
tumour
Depth Dose curves – photon and proton
MV x-rays
Ken Peach A Laser Afternoon: Introduction Imperial College, December 13th 2012 5
Relative Biological Effectiveness (RBE) & Linear Energy Transfer (LET)
• LET is related to dE/dx (Bethe Bloch)
but is the energy transferred to the medium,
not the energy lost by the particle
test
rayx
DOSEDOSE
RBE
dxdE
LET dtransferre
Ken Peach A Laser Afternoon: Introduction Imperial College, December 13th 2012 6
RBE
• The recommended value of RBE for protons is 1.1
photon & proton irradiation
Averaged survival fractions over 3 repeated experiments.
23/Jan/2012 PTCRi Meeting 7
After AI Nagano (PTCRi, private communication)
Dose (Gy)
Ken Peach A Laser Afternoon: Introduction Imperial College, December 13th 2012 8
Therapy Parameters: Energy30 cm
thickness of human bodyRadiography
300 MeV (p)550 MeV/u (C)
Ken Peach A Laser Afternoon: Introduction Imperial College, December 13th 2012 9
Summary of Therapy Requirements
Ken Peach A Laser Afternoon: Introduction Imperial College, December 13th 2012 10
Summary of Radiobiology Desiderata
• Energy reach – Protons, helium, lithium, carbon, oxygen
• to at least 10-100 mm• 20-120 MeV (p)• 60-220 MeV/u (C)
– Study mouse models in and away from the Bragg peak• Cell studies
– Probably down to a few MeV/u
• Flux– From single particle to >2 Gy/min
• Field– Micro- or Nano-beam to 100 x 100 mm2
Ken Peach A Laser Afternoon: Introduction Imperial College, December 13th 2012 11
Requirements for both
• Desired energy – energy within 1% of specification
• Small distribution of energy– s ~1%
• Desired flux– High flux – 1%– Single particle
• Precise transverse position– <0.5mm– ~microns (single particle)
Ken Peach A Laser Afternoon: Introduction Imperial College, December 13th 2012 12
c.f. characteristics of a LEIR Radiobiology facility
• Energy reach – Fully stripped 12C or 16O up to 240 MeV/u– 430 MeV/u (magnet limit) with new PS
• Possible beam lines– Horizontal (full energy)– Vertical (limited energy ~100 MeV/u)
• Large Hall – Currently used for storage– Space for radio biology laboratories
• Status: under consideration– Feasability study in progress– Funding?
• EU? Funding Agencies? Special budget?
Species C N O NeIntensity 1.4 109 0.4 109 1.1 109 0.25 109
Ken Peach A Laser Afternoon: Introduction Imperial College, December 13th 2012 13
WHERE COULD WE HELP?
Ken Peach A Laser Afternoon: Introduction Imperial College, December 13th 2012 14
A Compact Laser-Plasma Ion Source
• For radiobiology (see above)– Rapid change of ion species
• “Small” footprint– (shielding!)
• (few square metres)• Low(ish) cost
– Not defined, but “less than millions”• For therapy
– Use and an injector to a post-accelerator• FFAG-like (accelerate a spectrum)
• Later (20-30) years?– Full therapy system
Ken Peach A Laser Afternoon: Introduction Imperial College, December 13th 2012 15
SUMMARY AND CONCLUSION
Develop a simple plasma-driven ion source?reliable, reproducible, flexible, “cheap”
Radiobiologyeasier than therapy as a first phase
Therapy injectoruseful as a second phase
Therapyeventually aim for a compact CPT facility
Is there a possible funding source?